Abstract:Alcohol‐associated hepatitis (AH) has been demonstrated to affect multiple cell populations and their respective transcriptomes. The current study used Visium spatial transcriptomics and proteomics to identify global alterations between healthy human controls (non‐ALD) and AH participants. We observed an altered cellular landscape where proliferating AH hepatocyte transcriptomes mimicked cholangiocytes. Furthermore, mitochondria exhibited an overall decrease of transcripts while macrophages were increased in AH. This study characterized the cellular plasticity and profuse transcriptome changes that occur in human AH. Background Alcohol‐associated hepatitis (AH) is the clinical manifestation of alcohol‐associated liver disease (ALD). AH is a complex disease encompassing the dysregulation of many cells and cell subpopulations. This study used a hepatic spatial transcriptomic and proteomic approach (10X Genomics Visium) to identify hepatic cell populations and their associated transcriptomic and proteomic alterations in human AH. Methods Formalin‐fixed paraffin‐embedded liver tissue from AH patients (n = 2) and non‐ALD controls (donors) (n = 2) were used for Visium spatial transcriptomic and proteomic analysis. Results AH cell clusters and cell markers were drastically different in regard to tissue pattern and number of cell types compared to non‐ALD controls. Cholangiocytes, endothelial cells, macrophages, and stellate cells were more profuse in AH relative to non‐ALD controls. Transcriptionally, proliferating cell nuclear antigen‐positive (PCNA+) hepatocytes in AH more closely resembled cholangiocytes suggesting they were non‐functional hepatocytes derived from cholangiocytes. Furthermore, mitochondria protein‐coding genes were reduced in AH versus non‐ALD control hepatocytes, suggesting reduced functionality and loss of regenerative mechanisms. Macrophages in AH exhibited elevated gene expression involved in exosomes as compared to non‐ALD controls. The most upregulated macrophage genes observed in AH were those involved in exosome trafficking. Gene and protein signatures of disease‐associated hepatocytes (ANXA2+/CXCL1+/CEACAM8+) were elevated in AH and could visually identify a pre‐malignant lesion. Conclusions This study identified global cell type alterations in AH and distinct transcriptomic changes between AH and non‐ALD controls. These findings characterize cellular plasticity and profuse transcriptomic and proteomic changes that are apparent in AH and contribute to the identification of novel therapeutics.

Alcohol Cirrhosis Alters Nuclear Receptor and Drug Transporter Expression in Human Liver

Noncoding RNAs in Alcoholic Liver Disease

A serum metabonomic study on the difference between alcohol- and HBV-induced liver cirrhosis by ultraperformance liquid chromatography coupled to mass spectrometry plus quadrupole time-of-flight mass spectrometry.

Serum metabolomic analysis in cirrhotic alcohol-associated liver disease patients identified differentially altered microbial metabolites and novel potential biomarkers for disease severity

Is the Hypoxia-Inducible Factor-1 Alpha Mrna Expression Activated by Ethanol-Induced Injury, the Mechanism Underlying Alcoholic Liver Disease?

Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis

Insulin Resistance Enhances Binge Ethanol-Induced Liver Injury Through Promoting Oxidative Stress and Up-Regulation CYP2E1

Analysis of Differentially Expressed Genes and Micrornas in Alcoholic Liver Disease

Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers

Alarming Trends: Mortality from Alcoholic Cirrhosis in the United States

Associations Between Alcohol Use and Liver-Related Outcomes in a Large National Cohort of Patients With Cirrhosis

SLC3A2, as an indirect target gene of ALDH2, exacerbates alcohol-associated liver cancer via the sphingolipid biosynthesis pathway

Renal Transporter Alterations in Patients with Chronic Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination

Non-alcoholic fatty liver disease (NAFLD) – pathogenesis, classification, and effect on drug metabolizing enzymes and transporters

Systematic Transcriptome Analysis Reveals Elevated Expression of Alcohol‐metabolizing Genes in NAFLD Livers

Effects of alcohol consumption and tobacco smoking on the composition of the ensemble of drug metabolizing enzymes and transporters in human liver

Alcohol promotes liver fibrosis in high fat diet induced diabetic rats

A patient-based iPSC-derived hepatocyte model of alcohol-associated cirrhosis reveals bioenergetic insights into disease pathogenesis

Identification of Shared and Unique Key Biomarkers of Alcohol Liver Cirrhosis and Non-Alcoholic Steatohepatitis Through Machine Learning Network-Based Algorithms

Visium spatial transcriptomics and proteomics identifies novel hepatic cell populations and transcriptomic signatures of alcohol‐associated hepatitis

Cell-to-Cell Communications in Alcohol-Associated Liver Disease.